Biomica Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 (NCT05354102) | Biomica Ltd. | 2022-05-01 |
Track Biomica Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.